Khairy Jamaluddin says Malaysia cannot yet develop a Covid-19 vaccine because of the lack of facilities to produce human vaccines, prior focus on developing animal vaccines, and the early stage of Covid-19 vaccine research in Malaysia.
COVAX’s all-inclusive price of US$10.55 per dose of Covid-19 vaccines is nearly seven times cheaper than China-owned Sinopharm’s experimental coronavirus vaccine at US$72.50 per dose.